ARCHIVES

Who Makes This Drug? Secretive Contract Manufacturing Agreements Complicate Solutions to Shortages of Generics

This article is from The Cancer Letter archive.

Vol. 40 No. 01 | January 3, 2014

Download PDF Visit The Full Archive

Related Articles

Children’s Oncology Group to Select New Chairman; Four Leaders to Step Aside

April 28, 2000

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

Facility Needs Panel Recommends $4.5-3 billion, Seven Year Program To Be Run By NIGMS Or DRR

March 4, 1988

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011